Literature DB >> 9498763

CD38 functions are regulated through an internalization step.

A Funaro1, M Reinis, O Trubiani, S Santi, R Di Primio, F Malavasi.   

Abstract

The endocytosis of the human CD38 molecule has been investigated in normal lymphocytes and in a number of leukemia- and lymphoma-derived cell lines. CD38 internalization was followed using radioiodinated Abs in an acidic elution endocytosis assay to monitor the effects of cross-linking on internalization processes and to quantify the ratio of the internalized molecule. Second, conventional, confocal, and electron microscopies were used to evaluate the morphologic effects induced by ligation of the molecule with Abs mimicking the natural ligand(s). The results demonstrated that internalization is a reproducible phenomenon following CD38 ligation with both agonistic and nonagonistic specific Abs and involving only a fraction of the entire amount of the surface molecule. It is independent from signal transduction as can be inferred by the observation that 1) both agonistic and non agonistic Abs are effective and 2) the dynamic of internalization is much slower than that of cellular signaling. Morphologic studies demonstrated that endocytosis induced as a result of CD38 ligation presents a very specific pathway consisting of subcellular organelles fundamental to the processing of the complex. Our data indicate that down-regulation by endocytosis may be, in parallel with shedding, a regulatory element in activation and adhesion processes mediated by CD38. However, internalization seems not to be a key step in triggering intracellular signaling; more likely, it is a negative feedback control mechanism which interrupts signal transduction or cell-cell cross-talks mediated by membrane CD38.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498763

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Site-directed removal of N-glycosylation sites in BST-1/CD157: effects on molecular and functional heterogeneity.

Authors:  S Yamamoto-Katayama; A Sato; M Ariyoshi; M Suyama; K Ishihara; T Hirano; H Nakamura; K Morikawa; H Jingami
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

Review 2.  NAD+ surfaces again.

Authors:  Mathias Ziegler; Marc Niere
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

3.  Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion.

Authors:  James Boslett; Craig Hemann; Fedias L Christofi; Jay L Zweier
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-29       Impact factor: 4.249

4.  Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157).

Authors:  A Sato; S Yamamoto; K Ishihara; T Hirano; H Jingami
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

5.  The role of CD38 in Fcγ receptor (FcγR)-mediated phagocytosis in murine macrophages.

Authors:  John Kang; Kwang-Hyun Park; Jwa-Jin Kim; Eun-Kyeong Jo; Myung-Kwan Han; Uh-Hyun Kim
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

6.  Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel.

Authors:  Vivek Naranbhai; Salim S Abdool Karim; Marcus Altfeld; Natasha Samsunder; Raveshni Durgiah; Sengeziwe Sibeko; Quarraisha Abdool Karim; William H Carr
Journal:  J Infect Dis       Date:  2012-07-24       Impact factor: 5.226

7.  Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells.

Authors:  James D Johnson; Stanley Misler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

8.  Daratumumab induces CD38 internalization and impairs myeloma cell adhesion.

Authors:  Jayeeta Ghose; Domenico Viola; Cesar Terrazas; Enrico Caserta; Estelle Troadec; Jihane Khalife; Emine Gulsen Gunes; James Sanchez; Tinisha McDonald; Guido Marcucci; Balveen Kaur; Michael Rosenzweig; Jonathan Keats; Steven Rosen; Amrita Krishnan; Abhay R Satoskar; Craig C Hofmeister; Flavia Pichiorri
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

Review 9.  Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.

Authors:  Antonella Chillemi; Gianluca Zaccarello; Valeria Quarona; Manuela Ferracin; Chiara Ghimenti; Massimo Massaia; Alberto L Horenstein; Fabio Malavasi
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

10.  Isolation of hematopoietic stem cells and the effect of CD38 expression during the early erythroid progenitor cell development process.

Authors:  Işil Albenız; Leyla Türker-Şener; Aycan Baş; Ibrahim Kalelıoğlu; Rüstem Nurten
Journal:  Oncol Lett       Date:  2011-10-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.